Vahidi Serajoddin, Abedinzadeh Mehdi, Rahavian Amirhossein, Mirjalili Alimohammad, Sadeghi Ali, Karami Hormoz, Abouei Saeid
Andrology Research Center, Yazd Reproductive Science Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Department of Urology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Int J Reprod Biomed. 2023 Dec 19;21(11):943-948. doi: 10.18502/ijrm.v21i11.14658. eCollection 2023 Nov.
Clomiphene citrate (CC) has been suggested to increase the chance of sperm retrieval withmicrodissection testicular sperm extraction (micro-TESE). This study aimed to evaluate the effect of CC on micro-TESE results, due to the great controversy in this regard. 112 participants were included in this cross-sectional study and were divided into a case (n = 54) and a control group (n = 58) diagnosed with non-abstractive azoospermia. The case group received 25 mg of CC daily for 3 months, while the control group did not receive anything. All participants underwent micro-TESE by an andrologist, and at the end, the results were compared between groups. Hormone tests, including follicle-stimulating hormone, luteinizing hormone, testosterone, and prolactin were analyzed. The mean age of participants was the same in the case and the control groups, and no significant relationship was observed between the 2 groups (p = 0.16). 25.9% of sperm and 31.0% of sperm were observed and extracted in the CC-treated and the control group, respectively. Our findings showed that after receiving CC, the number of sperm extraction did not increase but it rather decreased. However, the initial level of hormones such as testosterone, follicle-stimulating hormone, luteinizing hormone, and prolactin, and the men's age, testicle size, smoking, and opium addiction, underlying diseases had no significant relationship in the 2 groups and did not affect the results.
枸橼酸氯米芬(CC)已被认为可增加显微外科睾丸精子提取术(micro-TESE)获取精子的几率。鉴于这方面存在很大争议,本研究旨在评估CC对micro-TESE结果的影响。112名参与者被纳入这项横断面研究,他们被分为病例组(n = 54)和对照组(n = 58),均被诊断为非梗阻性无精子症。病例组每天服用25毫克CC,持续3个月,而对照组未接受任何治疗。所有参与者均由男科医生进行micro-TESE,最后比较两组结果。分析了包括促卵泡激素、促黄体生成素、睾酮和催乳素在内的激素检测结果。病例组和对照组参与者的平均年龄相同,两组之间未观察到显著相关性(p = 0.16)。CC治疗组和对照组分别观察到并提取了25.9%和31.0%的精子。我们的研究结果表明,接受CC治疗后,精子提取数量并未增加,反而减少。然而,睾酮、促卵泡激素、促黄体生成素和催乳素等激素的初始水平,以及男性的年龄、睾丸大小、吸烟和鸦片成瘾情况、基础疾病在两组中均无显著相关性,也未影响结果。